Evidence map›Paper›PMID 32318759›Full record

ReviewCellular and molecular life sciences : CMLS2020

A chromatin perspective on metabolic and genotoxic impacts on hematopoietic stem and progenitor cells.

Zhenhua Yang, Hao Jiang

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Molecular regulation of hematopoietic stem cell quiescence.Cellular and molecular life sciences : CMLS · 2022
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Zhenhua YangSchool of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. zhenhua@hust.edu.cn.
Hao JiangDepartment of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, 22908, USA. hj8d@virginia.edu.
Huazhong University of Science and Technology · CNUniversity of Virginia · US

Funding

Regulation of hematopoietic stem and progenitor cell fate determination by Dpy30R01DK105531 · NIDDK · UNIVERSITY OF VIRGINIA · PI JIANG, HAO · 2015 to 2019
$1.8M
American Cancer Society 128609-RSG-15-166-01-DMCLeukemia and Lymphoma Society 1354-19NIDDK NIH HHS R01 DK105531NIDDK NIH HHS R01DK105531
6 · The paper itself

Abstract

Fate determination in self-renewal and differentiation of hematopoietic stem and progenitor cells (HSCs and HPCs) is ultimately controlled by gene expression, which is profoundly influenced by the global and local chromatin state. Cellular metabolism directly influences the chromatin state through the dynamic regulation of the enzymatic activities that modify DNA and histones, but also generates genotoxic metabolites that can damage DNA and thus pose threat to the genome integrity. On the other hand, mechanisms modulating the chromatin state impact metabolism by regulating the expression and activities of key metabolic enzymes. Moreover, through regulating either DNA damage response directly or expression of genes involved in this process, chromatin modulators play active and crucial roles in guarding the genome integrity, breaching of which results in defective HSPC function. Therefore, HSPC function is regulated by the dynamic and two-way interactions between metabolism and chromatin. Here, we review recent advances that provide a chromatin perspective on the major impacts the metabolic and genotoxic factors can have on HSPC function and fate determination.

Indexed as

AnimalsCell DifferentiationChromatinDNA DamageHematopoietic Stem CellsHistonesHumansChromatinHistonesChromatinDemethylationDNA damage responseGenome integrityHematopoietic stem cellsHistone modificationsMetabolism

Identifiers

PMID32318759
PMCPMC7541408
OpenAlexW3016497669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.